Discontinuation Rate Among Copper IUD Users

NCT ID: NCT03404102

Last Updated: 2018-01-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

400 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-10-17

Study Completion Date

2018-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The intrauterine device (IUD) is one of the most widely used reversible, long-term contraceptive methods in the world. But despite all its advantages; discontinuation rate of IUD ranged from 9.6% to 37.3 % (according to Demographic and Health Surveys data). In Egypt, in 2014, the discontinuation rate of IUD (within 12 months of use) was 14.3%.This study explores the differences around this rate in Egyptian university clinic and primary healthcare clinic with detailed percentages of possible causes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of the study is to compare between primary health care unit and university family planning clinic in discontinuation rate among copper IUD users.

1. The Research Hypothesis: (Null hypothesis)

• In women using copper IUD, discontinuation rate in primary health care unit and university clinic may be similar.
2. The Research Question:

• In women using copper IUD, Does discontinuation rate in primary health care unit and university clinic differ?
3. METHODOLOGY:

Patients and Methods

• Study setting:

* Family planning Outpatient clinic of Ain Shams Maternity Hospital, (ASUMH)
* primary health care unit in ain shams area

• Study population:
* Study period: 1 year
* Sample size: was calculated using Sample size computer program 11. After review of literature, no previous similar study was done before, so assume a discontinuation rate of 50% among Cu-IUD users in primary healthcare unit and 25% among Cu-IUD users in university clinic. Based on these values; the study will include 170 Cu-IUD users; equally selected as 85 subjects from each clinic. But due to the expected drop outs, recruitment will start by 200 women from each clinic.

* Statistics:

* Descriptive statistics for measured variables will be expressed as range, mean and standard deviation (for metric data); range, median and interquartile range (for discrete data); and number and proportions (for categorical data). Cu-IUD discontinuation findings in each clinic will be compared using the t-test or the Mann-whitney U test depending on whether the measured parameters are guassian variables. A P-value of 0.05 or less will be considered statistically significant.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Contraceptive Device; Intrauterine

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

university clinic

* Enrollment: 200 Subjects will be enrolled from women attending family planning clinic for Cu- IUD insertion
* Informed Consent: All participants will give their informed consent prior to enrollment.
* Data collection \& recording: Data of each patient will be recorded in a Case Record Form (CRF).
* Follow up visits /questionnaire: will be conducted from each subject at 6 months and 12 months after Cu-IUD insertion. User satisfaction score and haemoglobin serum level will be included in the questionnaire.

Cu-IUD

Intervention Type DEVICE

Copper Intra-uterine device used as contraceptive method

primary healthcare unit clinic

* Enrollment: 200 Subjects will be enrolled from women attending family planning clinic for Cu- IUD insertion
* Informed Consent: All participants will give their informed consent prior to enrollment.
* Data collection \& recording: Data of each patient will be recorded in a Case Record Form (CRF).
* Follow up visits /questionnaire: will be conducted from each subject at 6 months and 12 months after Cu-IUD insertion. User satisfaction score and haemoglobin serum level will be included in the questionnaire.

Cu-IUD

Intervention Type DEVICE

Copper Intra-uterine device used as contraceptive method

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cu-IUD

Copper Intra-uterine device used as contraceptive method

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1\. Age from 18-49 years. 2. Women planning for Cu-IUD insertion as a contraceptive method.

Exclusion Criteria

* 1\. Any woman with condition included in Category 3 or 4 for Cu-IUD in medical eligibility criteria for contraceptive use (MEC) -World Health Organization-2015.
Minimum Eligible Age

18 Years

Maximum Eligible Age

49 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

noha mohamed elzaydy

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

noha mohamed elzaydy

researcher

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ain Shams Maternity Hospital

Role: STUDY_DIRECTOR

Ain Shams Maternity Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ain Shams Maternity hospital

Cairo, Ain Shams, Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

noha elzaydy, M.B.B.Ch.

Role: CONTACT

01008309518 ext. 202

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ain Shams Maternity hospital

Role: primary

02-26845870 ext. 202

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Cu-IUD

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.